Cocrystal Pharma (COCP) Non Operating Income (2016 - 2026)
Cocrystal Pharma (COCP) reported Non Operating Income of $57000.0 for Q1 2026, up 42.5% on a YoY basis from $40000.0 in Q1 2025, and up 3.64% sequentially from $55000.0 in Q4 2025.
Cocrystal Pharma (COCP) Non Operating Income (2016 - 2026) Analysis & Trends
Cocrystal Pharma (COCP) has 11 years of Non Operating Income data on file, last reported at $57000.0 in Q1 2026.
- For the quarter ending Q1 2026, Non Operating Income rose 42.5% year-over-year to $57000.0; the trailing twelve-month figure through Mar 2026 stood at $205000.0 (down 3.3% YoY), and the FY2025 full-year result was $188000.0, down 49.73% from the prior year.
- Non Operating Income advanced to $57000.0 in Q1 2026, from $55000.0 in the prior quarter.
- In the past five years, Non Operating Income ranged from a high of $278000.0 in Q3 2023 to a low of -$78000.0 in Q1 2023.
- A 5-year average of $74125.0 and a median of $54000.0 in 2025 frame the typical range for Non Operating Income.
- Peak annual rise in Non Operating Income reached 20100.0% in 2023, while the deepest fall reached 2500.0% in 2023.
- Tracing COCP's Non Operating Income over 5 years: stood at $1000.0 in 2022, then soared by 20100.0% to $202000.0 in 2023, then plunged by 117.82% to -$36000.0 in 2024, then surged by 252.78% to $55000.0 in 2025, then advanced by 3.64% to $57000.0 in 2026.
- Business Quant data shows COCP's Non Operating Income at $57000.0 in Q1 2026, $55000.0 in Q4 2025, and $40000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | -9.22 Mn |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 444,000.00 |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 188.30 Mn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | 5.75 Mn |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | -8.59 Mn |
| 10 | Cocrystal Pharma | 12.57 Mn | 7.74 Mn | - | 57,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 57,000.00 |
| Dec 31, 2025 | 55,000.00 |
| Sep 30, 2025 | 40,000.00 |
| Jun 30, 2025 | 53,000.00 |
| Mar 31, 2025 | 40,000.00 |
| Dec 31, 2024 | -36,000.00 |
| Sep 30, 2024 | 103,000.00 |
| Jun 30, 2024 | 105,000.00 |
| Mar 31, 2024 | 202,000.00 |
| Dec 31, 2023 | 202,000.00 |
| Sep 30, 2023 | 278,000.00 |
| Jun 30, 2023 | 173,000.00 |
| Mar 31, 2023 | -78,000.00 |
| Dec 31, 2022 | 1,000.00 |
| Sep 30, 2022 | -6,000.00 |
| Mar 31, 2022 | -3,000.00 |
| Dec 31, 2021 | 17,000.00 |
| Sep 30, 2021 | 12,000.00 |
| Jun 30, 2021 | 7,000.00 |
| Dec 31, 2020 | -27,000.00 |